4//SEC Filing
Morabito Christopher 4
Accession 0000899243-21-019264
CIK 0001680581other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 4:30 PM ET
Size
5.6 KB
Accession
0000899243-21-019264
Insider Transaction Report
Form 4
Morabito Christopher
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-05-10+163,000→ 163,000 totalExercise: $10.01Exp: 2031-05-09→ Common Stock (163,000 underlying)
Footnotes (1)
- [F1]This option was granted on May 10, 2021 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of May 10, 2021. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001859284
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 4:30 PM ET
- Size
- 5.6 KB